STRYKER CORP SYK

Healthcare SIC 3841 - Surgical & Medical Instruments & Apparatus NAICS Manufacturing › Miscellaneous Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical and Medical Instrument Manufacturing derived NYSE

Last close 307.15 2026-10-23
Market cap $117.81B 2026-06-30 share count
52-week range 267.00 - 389.33

Valuation FY2025 figures against the last close

P/S4.7x
P/E36.6x
P/FCF27.5x
EV/EBITDA20.1x
Dividend yield1.1%
Diluted EPS8.40

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • Europe, Middle East, Africa
  • Asia Pacific
  • Other foreign countries
Revenue by geography, 4 categories over 3 years. The same figures are in the table below. FY2025 United States, FY2025: 19B (75.7%) 76% United States Europe, Middle East, Africa, FY2025: 3.2B (12.7%) 13% Asia Pacific, FY2025: 2.2B (8.6%) 9% Asia Pacific Other foreign countries, FY2025: 765M (3.0%) FY2024 United States, FY2024: 16.9B (75.0%) 75% Europe, Middle East, Africa, FY2024: 2.9B (12.8%) 13% Asia Pacific, FY2024: 2B (8.9%) 9% Other foreign countries, FY2024: 735M (3.3%) FY2023 United States, FY2023: 15.3B (74.4%) 74% Europe, Middle East, Africa, FY2023: 2.6B (12.8%) 13% Asia Pacific, FY2023: 1.9B (9.5%) 9% Other foreign countries, FY2023: 677M (3.3%)
Region FY2025FY2024FY2023
United States $19.01B $16.94B $15.26B
Europe, Middle East, Africa $3.18B $2.90B $2.62B
Asia Pacific $2.16B $2.02B $1.95B
Other foreign countries $765.0M $735.0M $677.0M

As the company reported it, from the “Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $25.12B$22.59B$20.50B$18.45B$17.11B$14.35B$14.88B$13.60B$12.44B$11.32B
Cost of revenue $9.05B$8.15B$7.44B$6.87B$6.14B$5.29B$5.19B$4.66B$4.26B$3.82B
Gross profit $16.07B$14.44B$13.06B$11.58B$10.97B$9.06B$9.70B$8.94B$8.18B$7.50B
R&D $1.62B$1.47B$1.39B$1.45B$1.24B$984.0M$971.0M$862.0M$787.0M$715.0M
SG&A $8.65B$7.68B$7.11B$6.39B$6.43B$5.36B$5.36B$5.10B$4.55B$4.14B
Total operating expenses $11.18B$10.75B$9.17B$8.74B$8.38B$6.83B$6.98B$6.40B$5.88B$5.33B
Operating income $4.89B$3.69B$3.89B$2.84B$2.58B$2.22B$2.71B$2.54B$2.30B$2.17B
Interest expense $607.0M$409.0M$363.0M———————
Pre-tax income $4.51B$3.49B$3.67B$2.68B$2.28B$1.95B$2.56B$2.36B$2.06B$1.92B
Income tax $1.27B$499.0M$508.0M$325.0M$287.0M$355.0M$479.0M$1.20B$1.04B$274.0M
Net income $3.25B$2.99B$3.17B$2.36B$1.99B$1.60B$2.08B$3.55B$1.02B$1.65B
EPS, basic 8.497.868.346.235.294.265.579.502.734.40
EPS, diluted 8.407.768.256.175.214.205.489.342.684.35
Shares, diluted (wtd. avg.) 386.5M385.6M383.7M382.2M382.3M380.3M379.9M380.3M380.1M378.5M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $4.01B$3.65B$2.97B$1.84B$2.94B$2.94B$4.34B$3.62B$2.54B$3.32B
Short-term investments $89.0M$91.0M$82.0M$84.0M$75.0M$81.0M$88.0M———
Receivables $4.04B$3.99B$3.77B$3.56B$3.02B$2.70B$2.89B$2.33B$2.20B$1.97B
Inventory $5.31B$4.77B$4.84B$4.00B$3.31B$3.49B$2.98B$2.96B$2.46B$2.03B
Total current assets $14.76B$14.85B$12.52B$10.28B$10.02B$9.71B$11.06B$9.73B$7.99B$7.86B
Property, plant and equipment $3.88B$3.45B$3.21B$2.97B$2.83B$2.75B$2.57B$2.29B$1.98B$1.57B
Goodwill $19.29B$15.86B$15.24B$14.88B$12.92B$12.78B$9.07B$8.56B$7.17B$6.36B
Other intangibles $5.68B$4.39B$4.59B$4.88B$4.84B$5.55B$4.23B$4.16B$3.48B$3.51B
Total assets $47.84B$42.97B$39.91B$36.88B$34.63B$34.33B$30.17B$27.23B$22.20B$20.43B
Short-term debt $1.00B$1.41B$2.09B$1.19B$7.0M$761.0M$859.0M$1.37B$632.0M$228.0M
Total current liabilities $7.79B$7.62B$7.92B$6.30B$4.55B$5.04B$4.40B$4.81B$3.48B$3.15B
Long-term debt $14.86B$12.19B$10.90B$11.86B$12.47B$13.23B$10.23B$8.49B$6.59B$6.69B
Total liabilities $25.42B$22.34B$21.32B$20.27B$19.75B$21.25B$17.36B$15.50B$12.22B$10.88B
Retained earnings $20.47B$18.53B$16.77B$14.77B$13.48B$12.46B$11.75B$10.77B$8.99B$8.84B
Total equity $22.42B$20.63B$18.59B$16.62B$14.88B$13.08B$12.81B$11.73B$9.98B$9.55B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $5.04B$4.24B$3.71B$2.62B$3.26B$3.28B$2.19B$2.61B$1.56B$1.92B
Depreciation and amortisation $1.57B$1.43B$1.34B$1.28B$1.27B$1.08B$1.04B$966.0M$859.0M$752.0M
Stock-based compensation $243.0M$229.0M$205.0M$168.0M$171.0M$142.0M$127.0M$119.0M$113.0M$97.0M
Capital expenditure $761.0M$755.0M$575.0M$588.0M$525.0M$487.0M$649.0M$572.0M$598.0M$490.0M
Investing cash flow -$4.87B-$3.00B-$962.0M-$2.92B-$859.0M-$4.70B-$1.46B-$2.86B-$1.61B-$4.19B
Financing cash flow $113.0M-$525.0M-$1.59B-$749.0M-$2.37B-$11.0M$3.0M$1.33B-$794.0M$2.26B
Dividends paid $1.28B$1.22B$1.14B$1.05B$950.0M$863.0M$778.0M$703.0M$636.0M$568.0M
Buybacks ————$0$0$307.0M$300.0M$230.0M$13.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000310764-26-000010.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 10B 20B 30B Revenue, FY2016: 11.3B Gross profit, FY2016: 7.5B Net income, FY2016: 1.6B Revenue, FY2017: 12.4B Gross profit, FY2017: 8.2B Net income, FY2017: 1B Revenue, FY2018: 13.6B Gross profit, FY2018: 8.9B Net income, FY2018: 3.6B Revenue, FY2019: 14.9B Gross profit, FY2019: 9.7B Net income, FY2019: 2.1B Revenue, FY2020: 14.4B Gross profit, FY2020: 9.1B Net income, FY2020: 1.6B Revenue, FY2021: 17.1B Gross profit, FY2021: 11B Net income, FY2021: 2B Revenue, FY2022: 18.4B Gross profit, FY2022: 11.6B Net income, FY2022: 2.4B Revenue, FY2023: 20.5B Gross profit, FY2023: 13.1B Net income, FY2023: 3.2B Revenue, FY2024: 22.6B Gross profit, FY2024: 14.4B Net income, FY2024: 3B Revenue, FY2025: 25.1B Gross profit, FY2025: 16.1B Net income, FY2025: 3.2B FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $11.32B $12.44B $13.60B $14.88B $14.35B $17.11B $18.45B $20.50B $22.59B $25.12B
Gross profit $7.50B $8.18B $8.94B $9.70B $9.06B $10.97B $11.58B $13.06B $14.44B $16.07B
Net income $1.65B $1.02B $3.55B $2.08B $1.60B $1.99B $2.36B $3.17B $2.99B $3.25B

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Cybersecurity incident A cybersecurity incident the company has determined to be material. Required since December 2023. Item 1.05
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Other event Item 8.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3841

TickerCompanyMarket capP/ERevenue growth
MMM 3M CO $89.46B 28.9x 1.5%
BSX BOSTON SCIENTIFIC CORP $66.22B 23.6x 19.9%
BDX BECTON DICKINSON & CO $54.18B 34.2x 8.2%
RMD RESMED INC $36.48B 24.2x 9.9%
DXCM DEXCOM INC $29.41B 37.3x 15.6%
MDLN Medline Inc. $29.20B — 11.5%
WST WEST PHARMACEUTICAL SERVICES INC $27.60B 57.8x 6.3%
SOLV Solventum Corp $14.54B 9.6x 0.9%